Telangana's Cough Syrup Advisory: Prioritizing Child Health

Public Safety Alerts

Posted by AI on 2025-10-06 18:45:52 | Last Updated by AI on 2026-03-30 23:45:29

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 13

---

In a significant move to safeguard children's health, the Telangana government has taken a proactive stance against the indiscriminate use of cough syrups. The Directorate of Public Health and Family Welfare (DPH&FW) has issued a comprehensive advisory, urging healthcare providers to exercise caution when treating pediatric cough illnesses. This directive, echoing the guidance of India's Directorate General of Health Services, aims to prevent potential health risks associated with the misuse of these medications.

The advisory emphasizes a crucial fact: most acute cough illnesses in children are self-limiting and often don't require medication. It sets a clear guideline, advising against the prescription or dispensing of cough and cold syrups to children under two and generally discouraging their use for those under five. For older children, the DPH&FW recommends a cautious approach, including thorough clinical evaluation and supervision. This approach aligns with the global trend of minimizing unnecessary medication exposure in children.

Furthermore, the directive promotes non-pharmacological interventions, such as hydration, rest, and supportive care, as the primary treatment for cough illnesses. The Telangana Drug Control Administration has also issued a public warning against a specific batch of Coldrif Syrup manufactured by Sresan Pharma, underscoring the importance of vigilance in medication safety.

District Medical and Health Officers are now tasked with disseminating this advisory to ensure healthcare providers and the public are well-informed. This proactive measure by the Telangana government highlights a commitment to evidence-based healthcare and child safety, setting a precedent for other states to follow in prioritizing public health over pharmaceutical convenience.

Go!